Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026)
Macrogenics (MGNX) reported Amortizatization of Intangibles of $737000.0 for Q1 2026, up 304.95% year-over-year from $182000.0 in Q1 2025, and up 14.44% quarter-over-quarter from $644000.0 in Q4 2025.
Macrogenics (MGNX) Amortizatization of Intangibles (2019 - 2026) Analysis & Trends
Macrogenics (MGNX) has 8 years of Amortizatization of Intangibles data on file, last reported at $737000.0 in Q1 2026.
- Amortizatization of Intangibles for Q1 2026 came in at $737000.0, up 304.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.2 million (up 31.37% YoY), and the FY2025 annual result was $1.6 million, down 41.35% from the prior year.
- Amortizatization of Intangibles rose to $737000.0 in Q1 2026 per MGNX's latest filing, from $644000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $1.9 million in Q3 2023 and troughed at -$334000.0 in Q1 2022.
- A 5-year average of $576235.3 and a median of $372000.0 in 2023 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles jumped 1771.43% in 2023, then tumbled 89.29% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at $337000.0 in 2022, then surged by 412.76% to $1.7 million in 2023, then tumbled by 89.29% to $185000.0 in 2024, then soared by 248.11% to $644000.0 in 2025, then advanced by 14.44% to $737000.0 in 2026.
- Business Quant data shows MGNX's Amortizatization of Intangibles at $737000.0 in Q1 2026, $644000.0 in Q4 2025, and $511000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Macrogenics | 260.14 Mn | 193.63 Mn | - | 737,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 737,000.00 |
| Mar 31, 2026 | 737,000.00 |
| Dec 31, 2025 | 644,000.00 |
| Dec 31, 2025 | 644,000.00 |
| Sep 30, 2025 | 511,000.00 |
| Sep 30, 2025 | 511,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Jun 30, 2025 | 311,000.00 |
| Mar 31, 2025 | 182,000.00 |
| Mar 31, 2025 | 182,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Dec 31, 2024 | 185,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Sep 30, 2024 | 371,000.00 |
| Jun 30, 2024 | 939,000.00 |
| Jun 30, 2024 | 939,000.00 |
| Mar 31, 2024 | 1.32 Mn |
| Mar 31, 2024 | 1.32 Mn |
| Dec 31, 2023 | 1.73 Mn |
| Dec 31, 2023 | 1.73 Mn |